BI 765883 / Boehringer Ingelheim - LARVOL DELTA

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=8 | Terminated | Sponsor: Boehringer Ingelheim | Trial completion date: Nov 2027 ➔ Jun 2025 | Active, not recruiting ➔ Terminated | Trial primary completion date: Apr 2027 ➔ Mar 2025; Primary endpoint not met

Monotherapy • Trial completion date • Trial primary completion date • Trial termination • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=8 | Active, not recruiting | Sponsor: Boehringer Ingelheim | N=68 ➔ 8

Enrollment change • Monotherapy • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=68 | Active, not recruiting | Sponsor: Boehringer Ingelheim | Recruiting ➔ Active, not recruiting

Enrollment closed • Monotherapy • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=68 | Recruiting | Sponsor: Boehringer Ingelheim | Trial primary completion date: Nov 2026 ➔ Apr 2027

Trial primary completion date • Hepatology • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=68 | Recruiting | Sponsor: Boehringer Ingelheim | Trial completion date: Oct 2027 ➔ Jan 2028 | Trial primary completion date: Jun 2026 ➔ Nov 2026

Monotherapy • Trial completion date • Trial primary completion date • Hepatology • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=68 | Recruiting | Sponsor: Boehringer Ingelheim | Trial completion date: Mar 2027 ➔ Oct 2027

Trial completion date • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=68 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Combination therapy • Enrollment open • Metastases • Monotherapy • Post-surgery • Surgery • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (clinicaltrials.gov) - P1 | N=68 | Not yet recruiting | Sponsor: Boehringer Ingelheim

Combination therapy • Metastases • Monotherapy • New P1 trial • Post-surgery • Surgery • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor